Skip to content
10-Q

Quarterly Report

VBI Vaccines Inc/BC

0001493152-24-019796

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 15, 2024 28.68M sh
Shares Diluted Q1 2024 · Mar 31, 2024 24.58M sh
Shares Diluted Q1 2024 · Mar 31, 2023 8.61M sh
Capex Q1 2024 · Mar 31, 2024 $151K
Capex Q1 2024 · Mar 31, 2023 $534K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$11.77M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$21.66M
Short Term Debt Q1 2024 · Mar 31, 2024 $48.75M
Short Term Debt Q1 2024 · Dec 31, 2023 $50.77M
Stockholders Equity Q1 2024 · Mar 31, 2024 −$5.47M
Stockholders Equity Q1 2024 · Dec 31, 2023 $7.53M
Stockholders Equity Q1 2024 · Mar 31, 2023 $45.02M
Stockholders Equity Q1 2024 · Dec 31, 2022 $64.16M
Current Liabilities Q1 2024 · Mar 31, 2024 $77.59M
Current Liabilities Q1 2024 · Dec 31, 2023 $75.74M
Current Assets Q1 2024 · Mar 31, 2024 $26.36M
Current Assets Q1 2024 · Dec 31, 2023 $36.23M
Total Assets Q1 2024 · Mar 31, 2024 $75.44M
Total Assets Q1 2024 · Dec 31, 2023 $86.95M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.73
Eps Diluted Q1 2024 · Mar 31, 2023 −$3.22
Eps Basic Q1 2024 · Mar 31, 2024 −$0.73
Eps Basic Q1 2024 · Mar 31, 2023 −$3.22
Sga Expense Q1 2024 · Mar 31, 2024 $7.67M
Sga Expense Q1 2024 · Mar 31, 2023 $13.28M
Rd Expense Q1 2024 · Mar 31, 2024 $2.57M
Rd Expense Q1 2024 · Mar 31, 2023 $3.15M
Net Income Q1 2024 · Mar 31, 2024 −$17.9M
Net Income Q1 2024 · Mar 31, 2023 −$27.75M
Operating Income Q1 2024 · Mar 31, 2024 −$11.75M
Operating Income Q1 2024 · Mar 31, 2023 −$19.51M
Revenue Q1 2024 · Mar 31, 2024 $1.21M
Revenue Q1 2024 · Mar 31, 2023 $485K